Modified treat-to-target approach paves road to LDA, remission in RA during pregnancy
03 Apr 2021
byJairia Dela Cruz
Low disease activity (LDA) and remission in women with rheumatoid arthritis (RA) can be easily achieved during pregnancy with the help of a modified treat-to-target (T2T) approach that incorporates the use of tumour necrosis factor inhibitors (TNFIs), as shown in the PreCARA* study.
Modified treat-to-target approach paves road to LDA, remission in RA during pregnancy
03 Apr 2021
